Thermo Fisher Scientific (Japan)

Thermo Fisher Scientific (Japan)

Thermo Fisher Scientific Inc. is an American life, science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Thermo Fisher Scientific (Japan), Japan, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

50%


Total
Publications

469


Total Open
Publications

233


Total
Citations

5.6K


Open Access
Percentage

50%


Total
Publications

469


Total Open
Publications

233


Total
Citations

5.6K

Wikipedia

Website

download

Breakdown

29% 16% 5% 50%

Publisher Open

29%

Both

16%

Other Platform Open

5%

Closed

50%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

56

Hybrid 16%

34

No Guarantees 57%

120

Other Platform Open

Domain 54%

52

Other Internet 24%

23

Preprint 21%

20

Institution 18%

17

Public 11%

11

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
50
Europe PMC
Domain
33
Semantic Scholar
Public
11
Unknown Repository
Other Internet
10
bioRxiv
Preprint
10
DOI
Other Internet
8
Research Square
Preprint
7
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
3
RCAAP Project by FCT - Portuguese National Funding Agency for Science, Research and Technology - RCAAP Search Portal
Institution
3
University of Debrecen - University of Debrecen Electronic Archive
Institution
2
1 / 3

Data updated 7 April 2025

Share

Share

Share